Aktis Oncology
ID: 7642465Aktis Oncology is a biotechnology company discovering and developing a novel class of targeted radiopharmaceuticals.
3
Funding Rounds
$331.0m
Money raised
Recent Funding Rounds
Overview
Aktis Oncology is a biotechnology company discovering and developing a novel class of targeted radiopharmaceuticals.
- Website:
- Business model: B2B
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding
Funding series
Funding Series Analysis
The company Aktis Oncology has raised a total of $331m in funding over 3 rounds.
Key Insights:
- Aktis Oncology September 2024 Series B Funding Round: $175m
- Aktis Oncology Series A round (extension), August 26, 2022: $84m
- Aktis Oncology Series A round, March 2021: $72m
Industries
Aktis Oncology is active in the following industries: